Related Experiment Video
Updated: Mar 17, 2026

High-Throughput Metabolic Profiling for Model Refinements of Microalgae
Published on: December 4, 2021
Biologically active new metabolites from a Florida collection of Moorea producens
Omar M Sabry1,2, Douglas E Goeger1, William H Gerwick1,3
1a College of Pharmacy , Oregon State University , Corvallis , OR , USA.
Abstract:
A bioassay-guided investigation (cancer cell cytotoxicity) of a Moorea producens collection from Key West, Florida, led to the discovery of two new bioactive natural products [(+)-malyngamide Y and a cyclic depsipeptide, (+)-floridamide]. Their planar structures were deduced through extensive analysis of 1D and 2D NMR spectroscopic data and supported by HRFAB mass spectrometry. The new cyclic depsipeptide contains four amino acids units, including N-methyl phenylalanine, proline, valine and alanine, beside the unique unit, 2,2-dimethyl-3-hydroxy-octanoic acid. In addition to the discovery of these two new compounds, two previously reported metabolites were also isolated and identified from this cyanobacterial collection; (-)-C-12 lyngbic acid and the antibacterial agent (-)-malyngolide.
Related Concept Videos
Drug Metabolism: Phase II Reactions
Bioactivation and Tissue Toxicity
Biosynthesis of Lipids
Drug Metabolism: Phase I Reactions
Biosynthesis in Bacteria
Drug Biotransformation: Overview

